- £216.87bn
- £236.39bn
- $58.74bn
China emerges as obesity drug lab for Big Pharma
FTSE 100 rises on strong earnings; healthcare, industrials lead
Health Rounds: New blood test finds early risk for ovarian cancer
China emerges as obesity drug lab for Big Pharma
Health Rounds: New blood test finds early risk for ovarian cancer
AstraZeneca bolsters vaccine pipeline with US-biotech Omniose acquisition
Biotech rising star has lifeline from geopolitics
Deals of the day-Mergers and acquisitions
Live Markets: Biotech dealmaking keeps adding up
AstraZeneca rises after report on $10 bln bid for obesity drugmaker Rhythm
Live Markets: Before the bell: rotation out of AI rolls on ahead of BoE
Press Digest: Wall Street Journal - November 5
Rhythm shares close higher on report of AstraZeneca $10 bln takeover offer
AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say (updated)
AstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports
Brief: Astrazeneca Made $10 Billion Offer For Rhythm Pharmaceuticals- WSJ
FTSE 100 climbs 1% on banks, miners boost
FTSE 100 climbs 1% on banks, miners boost
Ftse 100 Notches Fourth Straight Day Of Gains As Oil Slides On Us: Iran deal hopes